Asterixis as a side effect of carbamazepine therapy.
A patient developed asterixis 13 weeks after starting a therapy with carbamazepine. Serum concentration of carbamazepine was within the therapeutic levels. Further factors which might have provoked asterixis were an impairment of pulmonary function and the combination with a neuroleptic and lithium. Since the latter risk factors had already been present for a long time, it may be assumed that the addition of carbamazepine triggered the development of asterixis.
Psychiatrische Abteilung, Sektor 3, Wagner-Jauregg-Krankenhaus, Linz, Osterreich.
H
H
Rittmannsberger
F
F
Leblhuber
R
R
Sommer
D014150:Antipsychotic Agents / Q000008:administration & dosage; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D014202:Tremor / Q000139:chemically induced*
D014150:Antipsychotic Agents; D002220:Carbamazepine